Recombinant Proteins (Biopharmaceuticals)

Specialized in gene expression, fermentation, and protein purification, Hanson Biotech has been developing a variety of recombinant proteins. The integrated competent R&D and bioprocess manufacturing experiences of Hanson Biotech will enable Hanson to provide customers with high quality recombinant protein products at a reasonable price (key members of Hanson Biotech have many years of industrial experiences of working with LG Life Sciences, a top biopharmaceutical company in Korea).

Hanson Biotech owns not only protein separation and analytical laboratory but also clean room bio-pilot facility which includes 300 L automatically controlled fermentor, continuous centrifuge, cell homogenizer, ultra-filtration units, and chromatography system.

Reagent grade human growth factors and cytokines such as bFGF, EGF, TGFb, BMP2, hGH, and hGM-CSF are produced from such facilities.

Some of the recombinant proteins will be manufactured in the CMO biopharmaceutical facility next to the bio-plant of Hanson Biotech, where its GMP certification is expected to be acquired from KFDA in two years.

Upon KFDA approval, topical biopharmaceutical products containing bFGF or GM-CSF will be launched. along with other biogeneric products.

Contract production of biopharmaceuticals, transfer of biopharmaceutical manufacturing technology, or any other business collaborations could be discussed with Dr. K. Han (e-mail: kbhan@hansonbio.com, mobile: +82-19-680-7095).

Recombinant Protein Production Facilities and Core Technologies

Reagent grade recombinant protein Information (Example)